Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectious diseases. Our platform technology induces exceptional memory T cell responses that provide robust and durable immunity. Corner seeks to transform standard of care, ushering in a new era of robust, rapid, patient-friendly and low-cost immunotherapies – even for the most difficult to treat diseases.
Fundz sees it the moment Corner Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
WatertownBiotechnologyHealth CareTherapeuticsresearch